Company: BIAF
Filing Date: 2025-05-27
Form Type: 424B5
Source: 0001641172-25-012410
Chunk: 16

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-27
Form: 424B5
Chunk 16
---
 shares of restricted stock are issued under our equity incentive plans, or we otherwise issue additional shares of common stock in the future, at a price less than the public offering price, there will be further dilution to the investors. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.

| S-7 |

<div align='center'>PLAN OF DISTRIBUTION</div>

We have entered into the Sales Agreement with WallachBeth pursuant to which we may issue and sell our common stock from time to time through WallachBeth acting as sales agent, subject to certain limitations, pursuant to this prospectus supplement and the accompanying base prospectus. The sales, if any, of shares made under the Sales Agreement will be made by any method that is deemed an “at the market offering” as defined in Rule 415 promulgated under the Securities Act, including sales made directly on or through the Nasdaq Stock Market or any other existing trading market in the United States for our common stock, sales made to or through a market maker other than on an exchange or otherwise, directly to WallachBeth as principal, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices and/or in any other method permitted by law.

Each time we wish to issue and sell common stock under the Sales Agreement, we will notify WallachBeth of the number of shares to be issued, the dates on which such sales are anticipated to be made, any minimum price below which sales may not be made and other sales parameters as we deem appropriate. Once we have so instructed WallachBeth, unless WallachBeth declines to accept the terms of the notice, WallachBeth has agreed to use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such shares up to the amount specified on such terms. The obligations of WallachBeth under the Sales Agreement to sell our common stock are subject to a number of conditions that we must meet. We may instruct WallachBeth not to sell common stock if the sales cannot be effected at or above the price designated by us from time to time. We or WallachBeth may suspend the offering of common stock upon notice and subject to other conditions.

We will pay WallachBeth commissions for its services in acting as